Get my own profile
Public access
View all74 articles
3 articles
available
not available
Based on funding mandates
Co-authors
GuangPing GaoVerified email at umassmed.edu
Eric ZinnHarvard UniversityVerified email at g.harvard.edu
Eva Andres-MateosAtsena TherapeuticsVerified email at atsenatx.com
Livia S CarvalhoUniversity of Western Australia / Lions Eye InstituteVerified email at uwa.edu.au
Soumitra RoyDistinguished Investigator, Ensoma, BostonVerified email at ensoma.com
zeger debyserKU LeuvenVerified email at med.kuleuven.be
Veerle Baekelandthoogleraar KU LeuvenVerified email at kuleuven.be
Jim RileyUniversity of PennsylvaniaVerified email at upenn.edu
Lili WangUniversity of pennsylvaniaVerified email at upenn.edu
Mohammadsharif TabebordbarCo-Founder and CSO at Kate TherapeuticsVerified email at katetherapeutics.com
George ChurchHarvard Medical SchoolVerified email at harvard.edu
Daniel J RaderProfessor of Medicine, University of PennsylvaniaVerified email at mail.med.upenn.edu
Graham SimmonsSenior Investigator, Vitalant Research InstituteVerified email at vitalant.org
Wei Leong ChewGenome Institute of Singapore, A*STARVerified email at gis.a-star.edu.sg
Kim Van Vliet, Ph.D.St. Johns River State CollegeVerified email at sjrstate.edu
Jean-Marc TaymansJPARC UMR837 (Inserm + Université de Lille 2)Verified email at inserm.fr
Sadik KassimDanaher (Genomic Medicines)Verified email at dhlifesciences.com
Carl JuneUniversity of PennsylvaniaVerified email at upenn.edu
Mariacarmela AlloccamitVerified email at mit.edu
Ravi A DesaiImperial College LondonVerified email at imperial.ac.uk
Follow
Luk H. Vandenberghe, Ph.D.
Grousbeck Family Chair in Gene Therapy, Associate Professor of Ophthalmology, Harvard University
Verified email at meei.harvard.edu - Homepage